Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	317.49	2.07	0.50
Graham Fair Price	-65.90	2015.73	5910.59
PEG	93.45	0.19	-0.10
Price/Book	11.19	0.55	0.50
Price/Cash Flow	inf	0.00	28.91
Prices/Earnings	846.37	-21.23	2.24
Price/Sales	-6.32	1.73	1.85
Price/FCF	inf	0.00	28.91
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-5.71	0.38	0.40
Operating Margin	-24.17	0.20	0.26
ROA	-88.13	< 0.005	0.03
ROE	0.06	< 0.005	-88.25
ROIC	0.04	-0.02	-51.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.01	-0.02	50.13
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.32	-0.13	60.32
EPS QOQ	-0.23	-1.12	-389.20
FCF QOQ	-0.08	-1.00	-1103.92
Revenue QOQ	0.05	0.15	239.54
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	112.80	85.22	-24.45
Days Sales Outstanding (DSO)	79.35	62.31	-21.47
Inventory Turnover	0.80	1.06	32.37
Debt/Capitalization	0.12	0.11	-10.10
Quick Ratio	2.27	2.23	-1.66
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	5287.48	5260.81	-0.50
Cash	3134.96	2847.35	-9.17
Capex	0.00	0.00	0.00
Free Cash Flow	91.14	0.00	inf
Revenue	1422.84	1680.25	18.09
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.92	2.90	-0.92
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.74	-5.61	2.28
Naive Interpretation	Member

06 - Financial Health · Bad

Rating